Antibiotic cost savings from formulary restrictions and physician monitoring in a medical-school-affiliated hospital

data4.png

Combined savings from restricted antibiotics $2.61 per antibiotic day and $34,597 after formulary restrictions. 7.2% and 12.4% savings respectively from the pharmacy’s 1985 $18.45 average cost per antibiotic day and $199,003 average monthly expenditure. No significant changes in LOS or mortality for patients after restrictions.

Reference:
Woodward RS, Medoff G, Smith MD, Gray JL. Antibiotic Cost Savings from Formulary Restrictions and Physician Monitoring in a Medical-School-Affiliated Hospital. American Journal of Medicine, 1987 (83):817-823

Setting:
1,208-bed, tertiary-care teaching hospital, St. Louis, MO, USA

Key staff:
infectious disease physician

Resources Required:
76 hours per month for pharmacist, 24 hours per month for ID fellows, 10 hours per month for 4 faculty

Intervention:
Restriction-creation of formulary restrictions for vancomycin and select aminoglycocides and cephalosporins, which would require obtaining ID approval for use. ID told not to reject requests but to use persuasion.

Impact:
Combined savings from restricted antibiotics $2.61 per antibiotic day and $34,597 after formulary restrictions. 7.2% and 12.4% savings respectively from the pharmacy’s 1985 $18.45 average cost per antibiotic day and $199,003 average monthly expenditure. No significant changes in LOS or mortality for patients after restrictions.


Adventure Administrator

Adventure Studios was established in 2006 as a design and development firm offering an alternative to the typical models of executive software services available, including 100% custom construction, an expensive and time-intensive process, or the “one-size-fits-all” services that either lack necessary features or are encumbered by too many.

http://www.adventurestudio.com
Previous
Previous

Antibiotic streamlining from combination therapy to monotherapy utilizing an interdisciplinary approach

Next
Next

Controlling cephalosporin and aminoglycoside costs through pharmacy and therapeutics committee restrictions